Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 20 studies | 26% ± 10% | |
| glutamatergic neuron | 10 studies | 55% ± 20% | |
| neuron | 8 studies | 37% ± 17% | |
| endothelial cell | 8 studies | 26% ± 10% | |
| GABAergic neuron | 8 studies | 41% ± 19% | |
| endothelial cell of lymphatic vessel | 6 studies | 22% ± 4% | |
| amacrine cell | 5 studies | 38% ± 17% | |
| interneuron | 5 studies | 45% ± 20% | |
| deuterosomal cell | 4 studies | 22% ± 5% | |
| secretory cell | 4 studies | 20% ± 3% | |
| retinal ganglion cell | 4 studies | 34% ± 17% | |
| regulatory T cell | 4 studies | 20% ± 4% | |
| respiratory goblet cell | 3 studies | 22% ± 6% | |
| GABAergic interneuron | 3 studies | 32% ± 11% | |
| granule cell | 3 studies | 19% ± 1% | |
| epithelial cell | 3 studies | 35% ± 10% | |
| luminal hormone-sensing cell of mammary gland | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 96% | 3339.49 | 2542 / 2642 | 98% | 23.07 | 693 / 705 |
| lung | 99% | 798.70 | 570 / 578 | 96% | 15.69 | 1104 / 1155 |
| thymus | 100% | 1054.56 | 650 / 653 | 92% | 10.27 | 559 / 605 |
| intestine | 99% | 1087.04 | 954 / 966 | 91% | 9.59 | 479 / 527 |
| breast | 99% | 699.93 | 453 / 459 | 90% | 11.93 | 1006 / 1118 |
| pancreas | 93% | 672.95 | 306 / 328 | 94% | 14.94 | 168 / 178 |
| prostate | 100% | 1322.68 | 244 / 245 | 84% | 7.31 | 422 / 502 |
| uterus | 99% | 1773.85 | 169 / 170 | 81% | 11.88 | 372 / 459 |
| stomach | 86% | 447.25 | 307 / 359 | 91% | 9.78 | 259 / 286 |
| bladder | 100% | 1461.86 | 21 / 21 | 76% | 7.51 | 383 / 504 |
| ovary | 82% | 372.02 | 147 / 180 | 82% | 8.37 | 352 / 430 |
| kidney | 82% | 437.42 | 73 / 89 | 80% | 8.34 | 719 / 901 |
| esophagus | 72% | 413.91 | 1037 / 1445 | 88% | 17.34 | 161 / 183 |
| adrenal gland | 65% | 416.70 | 167 / 258 | 63% | 6.49 | 144 / 230 |
| skin | 66% | 305.97 | 1198 / 1809 | 50% | 6.01 | 238 / 472 |
| muscle | 100% | 1129.67 | 800 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1358.07 | 1324 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 98% | 627.59 | 1174 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 90% | 355.90 | 216 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 5.96 | 33 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 2.97 | 15 / 29 |
| heart | 48% | 207.24 | 413 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 42% | 186.29 | 387 / 929 | 0% | 0 | 0 / 0 |
| liver | 7% | 23.07 | 15 / 226 | 14% | 0.99 | 55 / 406 |
| eye | 0% | 0 | 0 / 0 | 10% | 0.37 | 8 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006006 | Biological process | glucose metabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0016868 | Molecular function | intramolecular phosphotransferase activity |
| GO_0047933 | Molecular function | glucose-1,6-bisphosphate synthase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | PGM2L1 |
| Protein name | Glucose 1,6-bisphosphate synthase (EC 2.7.1.106) (PMMLP) (Phosphoglucomutase-2-like 1) |
| Synonyms | BM32A |
| Description | FUNCTION: Glucose 1,6-bisphosphate synthase using 1,3-bisphosphoglycerate as a phosphate donor and a series of 1-phosphate sugars, including glucose 1-phosphate, mannose 1-phosphate, ribose 1-phosphate and deoxyribose 1-phosphate, as acceptors . In vitro, also exhibits very low phosphopentomutase and phosphoglucomutase activity which are most probably not physiologically relevant . . |
| Accessions | Q6PCE3 ENST00000298198.5 |